Collectively, these findings support a model in which MPO overexpression in advanced BLCA is linked to impaired N-glycan maturation and immune infiltration, with potential consequences for glycoprotein function and tumor progression, warranting in-depth investigations. The gene discussed is MPO; the disease is bladder transitional cell carcinoma.